GRI Bio Participates in Virtual Investor KOL Connect Segment
Albert Agro, PhD, CMO of GRI Bio recently participated in a Virtual Investor KOL Connect segment with prominent key opinion […]
NEXGEL’s Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection
LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical […]
Rapid7 Positioned as a Leader in IDC MarketScape for Worldwide SIEM for Enterprise
BOSTON, Sept. 18, 2024 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today […]
Great American Cookies and Marble Slab Creamery Launch Co-Branded Online Experience
New Ordering Journey Includes First-of-its-Kind 3D Cookie Cake Builder LOS ANGELES, Sept. 18, 2024 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. […]
Progress Awards 7 Scholarships Across the Globe for its 2024 Women in STEM Scholarship Series
Scholarships granted based on academic achievements, accomplishments in STEM and financial need BURLINGTON, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) — […]
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
– Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent – […]
Femasys Announces Infertility Clinic Customers from Coast to Coast
ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet […]
La Rosa Holdings to Participate in iAccess Alpha Buyside Best Ideas Fall Conference 2024 on September 24 and 25, 2024
Celebration, FL, Sept. 18, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding […]
Orangekloud SaaS Solutions to be Distributed in South Africa via MOU Signed with JPJ Medical
Singapore, Sept. 18, 2024 (GLOBE NEWSWIRE) — Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company […]
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company […]
